Summary: Based on the substantial morbidity and mortality, the importance of stroke prevention in Atrial Fibrillation, or AF, cannot be overestimated. Guidelines recommend that patients with AF receive some form of antithrombotic therapy typically coupled with intervention(s) that further reduce their risk of stroke through management of heart rate or rhythm. Stroke risk, however, is not homogenous and varies widely, complicating both the assessment of stroke risk and individualizing strategies for stroke prevention. An effective, but safety-driven approach to treatment, is essential. Join us as Drs. Abbott and Halperin discuss barriers in managing patients with AF, including 1) individualizing safe and effective oral anticoagulant (OAC) therapy; 2) developing longitudinal OAC treatment plans; and 3) addressing rate and rhythm control in appropriate patients. 0.5 CME Credits
